| Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer JL Allensworth, MK Evans, F Bertucci, AJ Aldrich, RA Festa, P Finetti, ... Molecular oncology 9 (6), 1155-1168, 2015 | 212 | 2015 |
| Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death MK Evans, A Tovmasyan, I Batinic-Haberle, GR Devi Free Radical Biology and Medicine 68, 302-314, 2014 | 83 | 2014 |
| X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity MK Evans, SJ Sauer, S Nath, TJ Robinson, MA Morse, GR Devi Cell death & disease 7 (1), e2073-e2073, 2016 | 59 | 2016 |
| XIAP regulation by MNK links MAPK and NFκB signaling to determine an aggressive breast cancer phenotype MK Evans, MC Brown, J Geradts, X Bao, TJ Robinson, MK Jolly, ... Cancer research 78 (7), 1726-1738, 2018 | 51 | 2018 |
| Differentiation of human pluripotent stem cells into neurons or cortical organoids requires transcriptional co-regulation by UTX and 53BP1 X Yang, B Xu, B Mulvey, M Evans, S Jordan, YD Wang, V Pagala, J Peng, ... Nature neuroscience 22 (3), 362-373, 2019 | 39 | 2019 |
| Ybx1 fine-tunes PRC2 activities to control embryonic brain development MK Evans, Y Matsui, B Xu, C Willis, J Loome, L Milburn, Y Fan, V Pagala, ... Nature communications 11 (1), 1-18, 2020 | 32 | 2020 |
| Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity CG Langdon, KE Gadek, MR Garcia, MK Evans, KB Reed, M Bush, ... Nature communications 12 (1), 5520, 2021 | 17 | 2021 |
| The role of oxidative stress in breast cancer GR Devi, JL Allensworth, MK Evans, SJ Sauer Cancer, 3-14, 2014 | 13 | 2014 |
| Investigation of the inter-molecular dynamics of non-dipolar molecules using the rotational velocity correlation function M Evans Journal of the Chemical Society, Faraday Transactions 2: Molecular and …, 1975 | 4 | 1975 |
| Manganese porphyrins in combination with ascorbate act as pro-oxidants and mediate caspase-independent cancer cell death. M Evans, A Tovmasyan, I Batinic-Haberle, G Devi Cancer Research 73 (8_Supplement), 5552-5552, 2013 | 2 | 2013 |
| Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma A Noll, C Myers, MC Biery, M Meechan, S Tahiri, A Rajendran, ME Berens, ... Neoplasia 43, 100921, 2023 | 1 | 2023 |
| Author Correction: Ybx1 fine-tunes PRC2 activities to control embryonic brain development MK Evans, Y Matsui, B Xu, C Willis, J Loome, L Milburn, Y Fan, V Pagala, ... nature communications 14, 2023 | 1 | 2023 |
| Structural and Functional Analysis of the Caspase–dependent and–independent Domains of the X-linked Inhibitor of Apoptosis Protein in Inflammatory Breast Cancer Tumor Biology MK Evans | 1 | 2016 |
| Elucidating a role for the translation initiation factor, eIF4G1, in resistance to therapy in inflammatory breast cancer (IBC) A Price, CM Edwards, MK Evans, G Devi Cancer Research 75 (15_Supplement), 1007-1007, 2015 | 1 | 2015 |
| Abstract P6-14-05: A novel link between anti-apoptotic signaling, NFκB, and SMAD7 in IBC pathobiology MK Evans, SJ Sauer, AJ Aldrich, J Geradts, P Vermeulen, L Dirix, ... Cancer research 75 (9_Supplement), P6-14-05-P6-14-05, 2015 | 1 | 2015 |
| Germline DICER1 loss promotes rhabdomyosarcoma via innate immune system R Larsen, J Hanna, K Reed, H Jin, W Kimbrough, K Vuong, M Evans, ... Cancer Research 84 (6_Supplement), 5463-5463, 2024 | | 2024 |
| Targeting CTPS1 and nucleotide biosynthesis pathways as a novel therapeutic approach in MYC-amplified medulloblastoma M Hathaway, H Jagana, M Meechan, J Hemenway, KE Gadek, A Miyaki, ... Cancer Research 84 (6_Supplement), 5107-5107, 2024 | | 2024 |
| Targeting Y box binding protein 1 (YBX1) in MYC-amplified medulloblastoma S Carney, J Hemenway, A Rajendran, M Hathaway, E Nealy, C Bonatto, ... Cancer Research 84 (6_Supplement), 561-561, 2024 | | 2024 |
| SYNERGISTIC EFFICACY OF Y BOX BINDING PROTEIN 1 (YBX1) INHIBITION COMBINED WITH CHEMOTHERAPY FOR THE TREATMENT OF MYC-AMPLIFIED MEDULLOBLASTOMA S Carney, C Bonatto, G Guadarrama, D Tailor, S Malhotra, M Evans NEURO-ONCOLOGY 25, 2023 | | 2023 |
| Ybx1 fine-tunes PRC2 activities to control embryonic brain development (jan, 10.1038/s41467-023-36069-z, 2023) MK Evans, Y Matsui, B Xu, C Willis, J Loome, L Milburn, Y Fan, V Pagala, ... NATURE COMMUNICATIONS 14 (1), 2023 | | 2023 |
